Pain Therapeutics, Inc. (PTIE) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pain Therapeutics, Inc. (PTIE)

PTIE 12.08

-1.3%

Jan 21 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: rkrw who wrote (6)	2/10/2006 10:52:48 AM
From: Jack@SI	of 28

The CEO did well putting together the King deal the particulars now well known. Remoxy is now a done deal with King potentially paying another $150 M in milestones and $100 M of expenses. Once approved King pays DRRX royalties. I like PTIE for Remoxy but the play now is in Oxytrex, an opioid painkiller solely owned by PTIE and with substantially fewer side effects and physical dependency than other opioids. It is true that the last PIII was messed up but PTIE plans to put an SPA in place and said there were no disagreements with the FDA about how that should be done. So what we have is a company with a great deal of cash, small burn rate with achievable milestones and a PIII coming on a $1B drug. Jack

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next